Top compounds associated with response to MTRNR2L8


Feature Type Standardized
Nominal ANOVA
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.041 0.3
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.039 0.3
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA ISOX CTRPv2 pan-cancer AAC 0.033 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.032 0.3
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.033 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA ZSTK474 CTRPv2 pan-cancer AAC 0.038 0.3
Download CSV